Cargando…

Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis

Detalles Bibliográficos
Autores principales:	Kawaguchi, Takumi, Torimura, Takuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013621/ https://www.ncbi.nlm.nih.gov/pubmed/34433256 http://dx.doi.org/10.3350/cmh.2021.0246

Ejemplares similares

Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis
por: Han, Ji Won, et al.
Publicado: (2022)

Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update
por: Fukui, Hiroshi
Publicado: (2021)

Sarcopenia as a prognostic indicator of liver cirrhosis
por: Kim, Sung‐Eun, et al.
Publicado: (2021)

Liver cirrhosis and sarcopenia: a dreadful combination
por: Kuchay, Mohammad Shafi, et al.
Publicado: (2022)

Leaky Gut, Leaky Brain?
por: Obrenovich, Mark E. M.
Publicado: (2018)

The Impact of Sarcopenia and Its Rate of Change on Prognostic Value of Liver Cirrhosis
por: Kang, Seong Hee, et al.
Publicado: (2018)

Changes in prognostic factors for patients with hepatocellular carcinoma underwent transarterial chemoembolization with the transition of the time: Child-Pugh class, Albumin-Bilirubin grade, and then
por: Kawaguchi, Takumi, et al.
Publicado: (2020)

Effects of isomaltulose on insulin resistance and metabolites in patients with non-alcoholic fatty liver disease: A metabolomic analysis
por: Kawaguchi, Takumi, et al.
Publicado: (2018)

Sarcopenia and Frailty in Liver Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma
por: Oh, Sooyeon, et al.
Publicado: (2020)

Myostatin and beyond in cirrhosis: all roads lead to sarcopenia
por: Dasarathy, Srinivasan
Publicado: (2017)

‘Leaky gut’ in hematological malignancies()
por: Costa-Lima, Carolina, et al.
Publicado: (2014)

MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
por: Kawaguchi, Takumi, et al.
Publicado: (2022)

Gut Microbiota, Leaky Gut, and Autoimmune Diseases
por: Christovich, Anna, et al.
Publicado: (2022)

Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota
por: Maslennikov, Roman, et al.
Publicado: (2023)

Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

Mechanisms of sarcopenia in liver cirrhosis and the role of myokines
por: Geladari, Eleni, et al.
Publicado: (2023)

The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease
por: Hartmann, Phillipp, et al.
Publicado: (2012)

The Role of Leaky Gut in Functional Dyspepsia
por: Wauters, Lucas, et al.
Publicado: (2022)

Hemp-Derived Nanovesicles Protect Leaky Gut and Liver Injury in Dextran Sodium Sulfate-Induced Colitis
por: Eom, Jung-Young, et al.
Publicado: (2022)

A Meta-Analysis of the Influence of Tumor Necrosis Factor-α-308 Gene Polymorphism on Liver Cirrhosis
por: Liu, Chang, et al.
Publicado: (2022)

Spleen and Liver
por: Torimura, Takuji
Publicado: (2016)

Clinical characteristics of sarcopenia in patients with alcoholic liver cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2021)

Sarcopenia in liver cirrhosis: perspectives from epigenetics and microbiota
por: Xu, Jia-qi, et al.
Publicado: (2023)

Retinoic Acid, Leaky Gut, and Autoimmune Diseases
por: Abdelhamid, Leila, et al.
Publicado: (2018)

Leaky gut biomarkers in depression and suicidal behavior
por: Ohlsson, L., et al.
Publicado: (2018)

Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome
por: Kobayashi, Takashi, et al.
Publicado: (2022)

The process to overcome lung cancer sarcopenia
por: Kawaguchi, Yo
Publicado: (2023)

Retracted: A Meta-Analysis of the Influence of Tumor Necrosis Factor-α-308 Gene Polymorphism on Liver Cirrhosis
por: Healthcare Engineering, Journal of
Publicado: (2023)

Sarcopenia and Liver Cirrhosis—Comparison of the European Working Group on Sarcopenia Criteria 2010 and 2019
por: Traub, Julia, et al.
Publicado: (2020)

Consilience in sarcopenia of cirrhosis
por: Dasarathy, Srinivasan
Publicado: (2012)

Leaky Gut in IBD: Intestinal Barrier–Gut Microbiota Interaction
por: Yu, Shunying, et al.
Publicado: (2022)

The leaky gut and the gut microbiome in sepsis – targets in research and treatment
por: Chancharoenthana, Wiwat, et al.
Publicado: (2023)

Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells
por: Nakano, Dan, et al.
Publicado: (2022)

Association between Activity and Brain-Derived Neurotrophic Factor in Patients with Non-Alcoholic Fatty Liver Disease: A Data-Mining Analysis
por: Hashida, Ryuki, et al.
Publicado: (2021)

Sealing the leaky pipeline: attracting and retaining women in cardiology
por: Cader, F Aaysha, et al.
Publicado: (2021)

Valine, a Branched-Chain Amino Acid, Reduced HCV Viral Load and Led to Eradication of HCV by Interferon Therapy in a Decompensated Cirrhotic Patient
por: Kawaguchi, Takumi, et al.
Publicado: (2012)

Gut Microbiota as Biosensors in Patients With Cirrhosis
por: Bajaj, Jasmohan S.
Publicado: (2019)

The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target
por: Kessoku, Takaomi, et al.
Publicado: (2021)

Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis
por: Hiramatsu, Akira, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5hvh8kmlpp3r28aotq14dr1k6c